<h2 id="intent">Intent &amp; Goal Setting</h2>
<p>AstraZeneca set out with one of the most ambitious Paris-aligned carbon targets in the healthcare sector, committing to a 98% reduction in absolute Scope 1 and 2 greenhouse (GHG) emissions by 2026 and a 50% reduction in absolute Scope 3 emissions by 2030 (from a 2019 baseline).</p>
<p>To get there, they applied the <b>Avoid &gt; Reduce &gt; Substitute &gt; Sequester</b> framework, questioning every process, challenging entrenched technologies, and refusing to rely on easy wins like unverified offsets. They developed a target approved by the Science-Based Targets initiative, developing a Paris-aligned pathway, ensuring targets were measurable, transparent, and aligned with the best available global climate science.</p>
<p><img loading="lazy" decoding="async" class="alignnone wp-image-2883 size-full" src="https://cms-live.futurebiogas.com/wp-content/uploads/2025/09/future-biogas-green-gas-case-studies-astrazenica-image-two.jpg" alt="Astrazeneca | Case Studies | Green Gas | Future Biogas" width="875" height="583" /></p>
<h3 id="planning">Careful Planning &amp; Partnership</h3>
<p>Engaging with Future Biogas was a natural progression in this journey. AstraZeneca sought not to purchase credits or Renewable Gas Guarantees of Origin (RGGOs) from a government subsidised plant, but to create new additional biomethane capacity that truly added capacity to the energy system. Together, both organisations committed to an intensive planning process that involved:</p>
<ul>
<li>Transparent accounting and open-book collaboration.</li>
<li>Long-term contracts that supported local farming communities and sustainable feedstocks.</li>
<li>Integrating carbon capture technologies to remove emissions at source.</li>
<li>Best practice standards, monitoring, verification and third-party accreditation to hold all parties to account.</li>
</ul>
<p>This was not a transactional arrangement — it was a strategic, long-term partnership, with both sides fully invested in the outcome.</p>
<p><img loading="lazy" decoding="async" class="alignnone wp-image-2882 size-full" src="https://cms-live.futurebiogas.com/wp-content/uploads/2025/09/future-biogas-green-gas-case-studies-astrazenica-image-one.jpg" alt="Astrazeneca | Case Studies | Green Gas | Future Biogas" width="875" height="583" /></p>
<h2 id="execution">Execution</h2>
<p>The result was the Moor Bioenergy Plant in Lincolnshire — the UK’s first unsubsidised biomethane plant dedicated to industry. By operating without subsidy, the project avoided any perception of greenwashing, ensuring AstraZeneca’s actions were rooted in genuine climate impact. The facility now supplies over 100 GWh of renewable energy annually, covering around 20% of AstraZeneca’s global gas use and displacing 18,000 tonnes of CO₂e emissions per year.</p>
<p>The plant also incorporates carbon capture, with captured CO₂ either repurposed industrially or permanently sequestered underground, further enhancing climate benefits and displacing another 14,000+ tonnes of CO₂ typically derived from fossil fuels.</p>
<h2 id="results">Results &amp; Impact</h2>
<p>Through Future Biogas, AstraZeneca is:</p>
<ul>
<li>Decarbonising healthcare by removing fossil gas from critical R&amp;D and manufacturing operations.</li>
<li>Strengthening UK green energy capacity, adding new unsubsidised generation to the energy mix.</li>
<li>Championing systemic change, showing how bold private investment can scale renewable gas without subsidies.</li>
<li>Inspiring others to follow suit, proving that unsubsidised, industry-grade biomethane is commercially viable today.</li>
</ul>
<h3 id="conclusion">Conclusion</h3>
<p>AstraZeneca’s partnership with Future Biogas demonstrates what happens when ambition meets innovation. By refusing to take shortcuts, embracing transparency, and investing in new capacity, they’ve set a new benchmark for industrial decarbonisation. This is not just a success story for biogas — it’s a blueprint for how global businesses can lead the energy transition with integrity.</p>
<p>&nbsp;</p>


Astrazeneca | Case Studies | Green Gas | Future Biogas

AstraZeneca & Future Biogas

<p>Nam accumsan purus sit amet imperdiet elementum. Cras faucibus at nisl ac luctus.Nam accumsan purus sit amet imperdiet elementum. Cras faucibus at nisl ac luctus.</p>


case-study-6

UK’s first unsubsidised biomethane plant online

Footer Menu

Header Menu

Header Menu 2

Header Mobile Menu

medium

thumbnail

slider_page_tag_small

title_text_card_repeater_image

recent_news_image

team_image

small_image_gallery

x_small_image_gallery

content_tab_image

slider_off_page

link_image_repeater_image

accordion_image

map_locations_image

tile_repeater_custom_small

tile_repeater_custom_large

slider_timeline

slider_off_page_people_tags

Privacy Policy

Policies

Terms & Conditions

<h3>5 Year</h3>
<p>Offtake options &#8211; fixed pricing linked to CPI</p>
<h3>10 Year</h3>
<p>Offtake options &#8211; fixed pricing linked to CPI</p>
<h3>15 Year</h3>
<p>Offtake options &#8211; fixed pricing linked to CPI</p>


We Can Offer

<h4>Zero carbon solution</h4>
<p>all independently audited with life cycle analysis and carbon intensity reporting.</p>
<h4>Unsubsidised low emission  biomethane</h4>
<p>means your company assumes full attribution for all climate benefits.</p>
<h4>Fully additional biomethane</h4>
<p>is 100% attributable to you, so you can operate with integrity and without fear of greenwashing.</p>


What You Get

Solutions

<p>Future Biogas can virtually sleeve unsubsidised biomethane via the existing gas grid to meet your gas demand. We develop new build new fully additional anaerobic digesters with Carbon Capture to meet demand. Green gas is load balanced through the grid with a full chain of custody proving that the gas you consume is met by equal green gas development.</p>


Unsubsidised Biomethane

Key Stats

Proven at Scale, Delivered Today

Case Study | UK’s first unsubsidised biomethane plant online

Further Case Studies